BioAtla, Inc.BCABNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P4
Near historical low
vs 5Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -30.29% |
| Q2 2025 | 10.76% |
| Q1 2025 | 6.05% |
| Q4 2024 | -28.94% |
| Q3 2024 | 1.22% |
| Q2 2024 | -14.08% |
| Q1 2024 | -16.86% |
| Q4 2023 | -20.16% |
| Q3 2023 | -8.27% |
| Q2 2023 | 42.69% |
| Q1 2023 | -0.81% |
| Q4 2022 | 10.26% |
| Q3 2022 | -4.21% |
| Q2 2022 | 22.38% |
| Q1 2022 | 2.89% |
| Q4 2021 | -0.63% |
| Q3 2021 | 11.47% |
| Q2 2021 | 42.47% |
| Q1 2021 | 2.26% |
| Q4 2020 | 109.56% |
| Q3 2020 | 66.40% |
| Q2 2020 | 75.98% |
| Q1 2020 | -50.21% |
| Q4 2019 | 0.00% |